Why Do Patients with Atopic Dermatitis Refuse to Apply Topical Corticosteroids?

Publisher： Karger

E-ISSN： 1421-9832|201|3|242-245

ISSN： 1018-8665

Source： Dermatology, Vol.201, Iss.3, 2000-11, pp. : 242-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial

By  

Dermatology, Vol. 222, Iss. 1, 2010-12 ,pp. : 36-48

Karger

Access to resources Recommend Favorite

Topical Tacrolimus for Atopic Dermatitis: Euphoria and Vigilance

By  

Dermatology, Vol. 203, Iss. 1, 2001-09 ,pp. : 1-2

Karger

Access to resources Recommend Favorite

Low Systemic Exposure after Repeated Topical Application of Pimecrolimus (Elidel®, SD Z ASM 981) in Patients with Atopic Dermatitis

By  

Dermatology, Vol. 204, Iss. 1, 2002-04 ,pp. : 63-68

Karger

Access to resources Recommend Favorite

R501X and 2282del4 Filaggrin Mutations Do Not Confer Susceptibility to Psoriasis and Atopic Dermatitis in Italian Patients

By  

Dermatology, Vol. 216, Iss. 1, 2007-11 ,pp. : 83-84

Karger

Access to resources Recommend Favorite

Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

By  

Dermatology, Vol. 211, Iss. 2, 2005-08 ,pp. : 174-187

Karger

Access to resources Recommend Favorite